LYCOS RETRIEVER Beta Retriever Home  |  What is Lycos Retriever?   
Organon: Companies
built 622 days ago
Rx&D Organon is a renowned pharmaceutical company with a strong commitment to health care. It is a truly global company, with products sold in more than 100 countries worldwide. More than half of these countries have an Organon subsidiary company.
organon 27 Globally, Organon is well-known for playing a key role in the development of the contraceptive pill, and the company is still currently active in gynaecology and fertility research. Other therapeutic areas of focus include anaesthesia, neuroscience and immunology.
To provide overall governance of the partnership, Organon and Ligand will establish a steering committee with three senior executives from each company. The chair of the steering committee will alternate between Organon and Ligand on an annual basis. Organon and Ligand ... will form a commercial committee to design and coordinate all sales, marketing and distribution activities for AVINZA. The commercial committee will be co-chaired by one Organon and one Ligand employee. The commercial committee will establish a clinical/regulatory subcommittee to design and coordinate all medical, clinical and regulatory activities for AVINZA.
Organon, based out of The Netherlands, has signed a collaboration agreement with Huya Bioscience International LLC to search for new, proprietary biopharmaceuticals or pharmaceutical compounds. As part of this collaboration, Organon has acquired an equity interest in Huya, a biopharmaceutical company focused on developing Chinese biopharmaceutical products.
Source:
Organon is recognized as a world leader in contraception and the treatment of reproductive disorders. Today, it remains one of only three pharmaceutical companies substantially involved in research and development into new contraceptive methods.
In the settlement, filed in U.S. District Court in New Jersey, Organon has agreed to pay a total of $36 million to consumers, states and insurance companies. Nationwide, consumers will receive approximately $7.5 million, with Washington consumers receiving up to $200,000. Washington state programs such as Medicaid and state hospitals could receive up to $100,000.
Source:
SEARCH
MORE ABOUT